SGCB and neoplasm: The authors successfully associated sGC downregulation and VSMC dysfunction in inflammatory disease states through NF-κB-responsive miR-155, known to be implicated in endothelial dysfunction, tumor progression, atherosclerosis, and vascular inflammation and permeability.